The 'Oscar of Science' Goes to Scientists: A Breakthrough in Vision Restoration 0 10

The world of science is applauding! Molecular biologist Jean Bennett and ophthalmologist Albert Maguire have been awarded the prestigious Breakthrough Prize for creating an innovative gene therapy. This development has the potential to restore lost vision, as confirmed by official statements on the prize's website.

Since the early 2000s, the Bennetts and Maguire, in collaboration with Dr. Katherine High, have dedicated themselves to developing a unique technology. Their goal was to treat Leber's amaurosis — a severe retinal disease that manifests in newborns or infants with a sudden deterioration of vision, involuntary eye movements, and increased sensitivity to light.

Years of hard work led to an astonishing result: the creation of the first-ever gene therapy for vision restoration, approved by the U.S. Food and Drug Administration (FDA). This revolutionary method works by replacing the defective RPE65 gene, which is critical for the retina's proper response to light.

Initial studies of this groundbreaking therapy were conducted by the Bennetts and Maguire on dogs, demonstrating promising results. In 2005, Dr. Katherine High, a prominent physician-scientist from the Children's Hospital of Philadelphia, invited them to join clinical trials in humans.

The evidence of the therapy's effectiveness is striking in its stability. "Positive results have proven to be durable: patients who underwent treatment more than ten years ago have shown stable improvements in vision," states the official announcement of the prize, confirming the long-term effect.

Future Prospects: Blindsight Implant

In 2024, renowned businessman Elon Musk made a splash by announcing the development of the Blindsight brain implant from his company Neuralink. This futuristic device has the potential to give sight to blind people. At the time of the announcement, the new technology was actively being tested on monkeys, and it was noted that no animal "sustained serious injuries from the devices" during the research process.